Fool.com
The World's Greatest Investing Community
Results 61 - 70 of 513 : Previous 3 4 5 6 7 8 9 10 11 Next
Don't Like High Drug Costs? Blame Canada.
Those "South Park" guys were right all along.
A list of promising companies chosen by investors who've already picked stocks that beat the market with huge gains.
Pfizer's Paying $2.3 Billion Again? Oh, Wait, Never Mind.
Get past the headline, Fools.
Pharma's Next Home Run Drug Could Be 4 Singles Instead
With mixed success in the women's health field, drugmakers try to turn a single compound into a treatment for several diseases and conditions.
Thinning Out Plavix's Monopoly
Another competitor's on the way.
Don't Let Dummy Pills Make You a Dummy Investor
The sugar pill is getting stronger.
10 Dividend Stocks for the Next Decade and Beyond
Opportunities like this don't come around often.
UnitedHealth lowers costs through an adherence-incentive program.
Companion tests are coming.
Elan and J&J, Sitting in a Tree ...
Johnson & Johnson dumps Alkermes for its new best bud.
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK